Sign In
Buy CVAC
$4.66
+0 (+0%)
At Close: Apr 02, 2026
CureVac Says Its Not Giving Up on a Covid-19 Vaccine and The Shares Are Soaring.
10:54am, Friday, 18'th Jun 2021
The CEO of the German company said on Thursday that CureVac hoped its vaccine candidate could still be of use after trial data showed it was a failure.
12 Words From CureVac's CEO That Could Mean Billions for Moderna and Pfizer
06:30am, Friday, 18'th Jun 2021
The news may reinforce Moderna's and Pfizer's vaccine-market dominance.
Curevac shares climb 10%; CFO says not giving up on COVID-19 vaccine
06:18am, Friday, 18'th Jun 2021
Shares of Curevac rose 10% in premarket trading on Friday. Shares of the German biotech have lost 48% this week after the company said a late-stage clinical trial of its COVID-19 vaccine was only 47%
Tesla Partner CureVac Says Will Find 'Sweet Spot' For COVID-19 Vaccine Despite Disappointing Data
02:14am, Friday, 18'th Jun 2021
CureVac N.V.'s (NASDAQ: CVAC) Chief Financial Officer Pierre Kemula is optimistic its COVID-19 vaccine could still be offered to certain age groups or as a booster, the Financial Times reported on Thu
What Did the Stock Market Do Today? 3 Big Stories to Catch Up On.
05:13pm, Thursday, 17'th Jun 2021
So what did the stock market do today? All eyes were on a World Bank decision and big moves in RIDE and CVAC stocks.
CureVac (CVAC) Plummets on Disappointing COVID-19 Vaccine Data
11:16am, Thursday, 17'th Jun 2021
CureVac (CVAC) down as it announces that its first-generation COVID-19 vaccine candidate, CVnCoV, did not meet the prespecified statistical success criteria in a phase IIb/III study.
CureVac collapses 45% after disappointing results from COVID-19 vaccine trial
11:15am, Thursday, 17'th Jun 2021
CureVac NV (NASDAQ: CVAC) slipped about 45% in the stock market on Thursday morning as the company said the late-stage trial showed its candidate COVID-19 vaccine to be only 47% effective, raising que
Why CureVac Stock Is Getting Crushed Today
11:06am, Thursday, 17'th Jun 2021
The biotech's COVID-19 vaccine candidate no longer appears to be viable.
Options Traders Swam Spiraling CureVac Stock
10:33am, Thursday, 17'th Jun 2021
One of the worst stocks on the Nasdaq this morning, the shares of CureVac BV (NASDAQ:CVAC) are spiraling, last seen down 48.8% to trade at $48.49.
CureVac shares drop 45% after disappointing Covid vaccine results
10:29am, Thursday, 17'th Jun 2021
Shares in CureVac plummeted on Thursday after the German biotech company said that interim trial results showed its experimental Covid-19 vaccine was only 47% effective in preventing symptomatic disea
Morning Stock Movers: CureVac, Citigroup, Newmont
08:14am, Thursday, 17'th Jun 2021
Jun.17 -- Bloomberg's Romaine Bostick runs down the biggest moving stocks in today's pre-market trading.
CureVac tumbles 41% in premarket on COVID-19 vaccine disappointment
06:44am, Thursday, 17'th Jun 2021
Shares of CureVac fell 42% in premarket trading on Thurdsay, a day after the German biotech said its COVID-19 vaccine was 47% effective in preventing the disease. CureVac's study, conducted in 10 coun
German biotech CureVac's stock plunges 50% after its COVID-19 vaccine candidate failed a clinical trial
06:26am, Thursday, 17'th Jun 2021
Interim analysis of data from about 40,000 volunteers showed the biotech's jab is only 47% effective, falling short of the study's criteria.
Coronavirus tally: Global cases of COVID-19 top 177 million and CureVac vaccine is just 47% effective
06:25am, Thursday, 17'th Jun 2021
The global tally for the coronavirus-borne illness headed above 177 million on Thursday, according to data aggregated by Johns Hopkins University, while deaths climbed above 3.8 million. The U.S. cont
CVAC Stock Price Falls Over 45% Pre-Market: Why It Happened
05:17am, Thursday, 17'th Jun 2021
The stock price of CureVac BV (NASDAQ: CVAC) fell by over 45% pre-market. This is why it happened.
